. 1986 Mar-Apr;5(2):61-2.

A controlled study of silver nitrate prophylaxis and the incidence of nasolacrimal duct obstruction

J F Hick et al. J Ophthalmic Nurs Technol. 1986 Mar-Apr.

. 1986 Mar-Apr;5(2):61-2.

No abstract available

Similar articles

A controlled study of silver nitrate prophylaxis and the incidence of nasolacrimal duct obstruction.
Hick JF, Block DJ, Ilstrup DM. Hick JF, et al. J Pediatr Ophthalmol Strabismus. 1985 May-Jun;22(3):92-3. doi: 10.3928/0191-3913-19850501-04. J Pediatr Ophthalmol Strabismus. 1985. PMID: 3998975 Clinical Trial.
[On the treatment of dacryocanaliculitis].
Sultanov MIu. Sultanov MIu. Vestn Oftalmol. 1999 Jan-Feb;115(1):31-2. Vestn Oftalmol. 1999. PMID: 10207319 Russian.
Imperforation of the nasolacrimal duct as a cause of nasal obstruction in the newborn.
Góralówna M, Tarantowicz W. Góralówna M, et al. Rhinology. 1979 Sep;17(3):173-5. Rhinology. 1979. PMID: 504908 No abstract available.
Nasal obstruction in the neonate secondary to nasolacrimal duct cysts.
Paoli C, François M, Triglia JM, Frydman E, Polonovski JM, Narcy P. Paoli C, et al. Laryngoscope. 1995 Jan;105(1):86-9. doi: 10.1288/00005537-199501000-00019. Laryngoscope. 1995. PMID: 7837921 Review. No abstract available.
Silver nitrate prophylaxis.
Schneider G. Schneider G. Can Med Assoc J. 1984 Aug 1;131(3):193-6. Can Med Assoc J. 1984. PMID: 6378348 Free PMC article. Review.

Characteristics of taste alterations in people receiving taxane-based chemotherapy and their association with appetite, weight, and quality of life.
Kaizu M, Komatsu H, Yamauchi H, Yamauchi T, Sumitani M, Doorenbos AZ. Kaizu M, et al. Support Care Cancer. 2021 Sep;29(9):5103-5114. doi: 10.1007/s00520-021-06066-3. Epub 2021 Feb 18. Support Care Cancer. 2021. PMID: 33604787 Free PMC article.